SVC Research Seminar: Dr. Jacqueline Ho

Jacqueline Ho, MD, assistant professor of pediatrics and of developmental biology, School of Medicine, will deliver the next lecture in the 2017 Senior Vice Chancellor’s Research Seminar series on Friday, April 7, from noon–1 p.m. in Lecture Room 6, Scaife Hall. [Add to Calendar] The title of Ho’s presentation is “Small RNAs and Small Kidneys: A Role for the miR-17~92 Cluster.” This seminar series is open to all interested University of Pittsburgh and Carnegie Mellon University faculty, students, and staff. Arthur S. Levine, MD, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of Medicine, will introduce Ho and lead the discussion following her lecture. 

Topic Overview:

The leading cause of chronic kidney disease and renal failure in children is abnormal development of the kidney and urinary tract. The risk of chronic kidney disease is linked to decreased renal reserve as a result of the formation of fewer and/or abnormal nephrons during kidney development. Furthermore, decreased congenital nephron endowment is associated with adult onset hypertension, a common health problem that leads to decreased life expectancy. Thus, understanding the molecular mechanisms that control nephron number and formation is critical to making an impact on these diseases. Ho and her colleagues have shown that the microRNA cluster miR-17~92 is important in regulating the proliferation of nephron progenitors in the developing kidney, which has important implications for congenital nephron endowment and subsequent kidney health in children and adults.

CME Information: 

The Center for Continuing Education in the Health Sciences will designate the Senior Vice Chancellor’s Research Seminar as a continuing medical education activity eligible for a maximum of one hour of Category 1 credit toward the AMA Physician’s Recognition Award. Nurses and other health professionals are awarded 0.1 Continuing Education Units (CEUs).

For information on future lectures in this series, which highlights the growing body of important research being accomplished by young investigators in the University of Pittsburgh’s Schools of the Health Sciences, please visit our website at http://www.svc-seminar.pitt.edu/ or call the Office of Academic Affairs at 412-383-7382.

Target Audience: 

Faculty and students from the University of Pittsburgh Schools of the Health Sciences, and other schools, departments, and units across campus, and Carnegie Mellon University faculty and students from the Department of Biological Sciences.

The University of Pittsburgh School of Medicine, as part of the Consortium for Academic Continuing Medical Education, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The Center for Continuing Education in the Health Sciences designates this continuing medical education activity for a maximum of one hour of Category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. 

Nurses and other health care professionals are awarded 0.1 Continuing Education Units (CEUs).

Disclosure Statement:

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials that will be distributed at the time of the conference.  

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us serve you better. Please notify us of your needs at least two weeks in advance of the program.

Disclaimer Statement:

“The information presented at this CME program represents the views and opinions of the individual presenters and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, University of Pittsburgh Medical Center (UPMC) or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for education subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment in considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.”

Follow Pitt Health Sciences (@PittHealthSci) on Twitter for the latest updates.